The success of APOPTO-SENSE 2.0 is the result of collaborative efforts from our team members, advisors, mentors, and external contributors. This page acknowledges everyone who supported our project, from conceptual design to experimental validation, human practices, education, and entrepreneurship. We are grateful for their guidance, resources, and expertise, which were essential in developing our synthetic biology platform for personalized cancer drug sensitivity testing.
All work was conducted by student team members, with advisors providing oversight and safety guidance. Below, we detail specific contributions by category.
We extend our deepest gratitude to all contributors for their invaluable support. Without their guidance, resources, and encouragement, APOPTO-SENSE 2.0 would not have been possible. Special thanks to our families and friends for their unwavering encouragement throughout the iGEM journey.